{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T08:16:23Z","timestamp":1788423383460,"version":"build-2803163510"},"reference-count":83,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T00:00:00Z","timestamp":1762992000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T00:00:00Z","timestamp":1762992000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100002383","name":"King Saud University","doi-asserted-by":"publisher","award":["ORF-RC-2025-x"],"award-info":[{"award-number":["ORF-RC-2025-x"]}],"id":[{"id":"10.13039\/501100002383","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Biotechnol"],"DOI":"10.1186\/s12896-025-01066-1","type":"journal-article","created":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T09:19:45Z","timestamp":1763025585000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["A novel pregabalin functionalized salicylaldehyde derivative loaded mesoporous silica nano scaffold: a prospective carrier for targeting inflammatory cytokine storm"],"prefix":"10.1186","volume":"25","author":[{"given":"Yasir","family":"Mehmood","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syeda Momena","family":"Rizvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Musarrat","family":"Ijaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamseela","family":"Shahzadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hira","family":"Shahid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shabbir","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akhtar","family":"Rasul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javed","family":"Iqbal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulrahman A.","family":"Almehizia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Bouallegue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Musaab","family":"Dauelbait","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esmael M.","family":"Alyami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,13]]},"reference":[{"issue":"3","key":"1066_CR1","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/S0028-3908(01)00181-2","volume":"42","author":"D Martin","year":"2002","unstructured":"Martin D, et al. Gabapentin-mediated Inhibition of voltage-activated Ca2\u2009+\u2009channel currents in cultured sensory neurones is dependent on culture conditions and channel subunit expression. Neuropharmacology. 2002;42(3):353\u201366.","journal-title":"Neuropharmacology"},{"issue":"8","key":"1066_CR2","doi-asserted-by":"publisher","first-page":"6267","DOI":"10.1016\/j.arabjc.2020.05.010","volume":"13","author":"A-W Ajlouni","year":"2020","unstructured":"Ajlouni A-W, et al. Nanocomposites of gold nanoparticles with pregabalin: the future anti-seizure drug. Arab J Chem. 2020;13(8):6267\u201373.","journal-title":"Arab J Chem"},{"issue":"3","key":"1066_CR3","doi-asserted-by":"publisher","first-page":"101877","DOI":"10.1016\/j.jksus.2022.101877","volume":"34","author":"MS Zafar","year":"2022","unstructured":"Zafar MS, et al. Suppression of cytokine storm and associated inflammatory mediators by salicylaldehyde derivative of pregabalin: an innovative perspective for alleviating airway inflammation and lung remodeling. J King Saud University-Science. 2022;34(3):101877.","journal-title":"J King Saud University-Science"},{"key":"1066_CR4","doi-asserted-by":"crossref","unstructured":"Keyhanfar F. Relative potency of pregabalin, gabapentin, and morphine in a mouse model of visceral pain Puissance relative de la pr\u00e9gabaline, de la gabapentine et de la morphine dans un modele de douleur visc\u00e9rale chez la souris. Can J Anesth\/J Can Anesth, 2013. 60: pp. 44\u201349.","DOI":"10.1007\/s12630-012-9813-6"},{"issue":"6","key":"1066_CR5","doi-asserted-by":"publisher","first-page":"e201600365","DOI":"10.1002\/ardp.201600365","volume":"350","author":"N Ahmad","year":"2017","unstructured":"Ahmad N, et al. A novel Pregabalin functionalized salicylaldehyde derivative afforded prospective pain, inflammation, and pyrexia alleviating propensities. Arch Pharm. 2017;350(6):e201600365.","journal-title":"Arch Pharm"},{"issue":"7","key":"1066_CR6","doi-asserted-by":"publisher","first-page":"506","DOI":"10.3109\/10611860903548362","volume":"18","author":"V Bali","year":"2010","unstructured":"Bali V, Ali M, Ali J. Novel nanoemulsion for minimizing variations in bioavailability of Ezetimibe. J Drug Target. 2010;18(7):506\u201319.","journal-title":"J Drug Target"},{"issue":"1","key":"1066_CR7","first-page":"32","volume":"64","author":"A Silva","year":"2009","unstructured":"Silva A, et al. Development of topical nanoemulsions containing the isoflavone genistein. Die Pharmazie-An Int J Pharm Sci. 2009;64(1):32\u20135.","journal-title":"Die Pharmazie-An Int J Pharm Sci"},{"issue":"2","key":"1066_CR8","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1021\/mp700091j","volume":"5","author":"J-B Tagne","year":"2008","unstructured":"Tagne J-B, et al. A nanoemulsion formulation of Tamoxifen increases its efficacy in a breast cancer cell line. Mol Pharm. 2008;5(2):280\u20136.","journal-title":"Mol Pharm"},{"issue":"4","key":"1066_CR9","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1158\/0008-5472.CAN-08-3231","volume":"69","author":"C Khemtong","year":"2009","unstructured":"Khemtong C, et al. In vivo off-resonance saturation magnetic resonance imaging of \u03b1v\u03b23-targeted superparamagnetic nanoparticles. Cancer Res. 2009;69(4):1651\u20138.","journal-title":"Cancer Res"},{"issue":"28","key":"1066_CR10","doi-asserted-by":"publisher","first-page":"7386","DOI":"10.1016\/j.biomaterials.2010.06.004","volume":"31","author":"T-H Kim","year":"2010","unstructured":"Kim T-H, et al. The delivery of doxorubicin to 3-D multicellular spheroids and tumors in a murine xenograft model using tumor-penetrating triblock polymeric micelles. Biomaterials. 2010;31(28):7386\u201397.","journal-title":"Biomaterials"},{"key":"1066_CR11","doi-asserted-by":"crossref","unstructured":"Hughes GA. Nanostructure-mediated drug delivery, in Nanomedicine in Cancer. 2017, Pan Stanford. pp. 47\u201372.","DOI":"10.1201\/b22358-2"},{"issue":"4","key":"1066_CR12","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/S1359-0286(02)00117-1","volume":"6","author":"M Hans","year":"2002","unstructured":"Hans M, Lowman A. Biodegradable nanoparticles for drug delivery and targeting. Curr Opin Solid State Mater Sci. 2002;6(4):319\u201327.","journal-title":"Curr Opin Solid State Mater Sci"},{"issue":"3","key":"1066_CR13","doi-asserted-by":"publisher","first-page":"124","DOI":"10.4103\/2230-973X.160844","volume":"5","author":"C Bharti","year":"2015","unstructured":"Bharti C, et al. Mesoporous silica nanoparticles in target drug delivery system: A review. Int J Pharm Invest. 2015;5(3):124.","journal-title":"Int J Pharm Invest"},{"issue":"13","key":"1066_CR14","doi-asserted-by":"publisher","first-page":"7240","DOI":"10.1039\/C5NR09112H","volume":"8","author":"L Maggini","year":"2016","unstructured":"Maggini L, et al. Breakable mesoporous silica nanoparticles for targeted drug delivery. Nanoscale. 2016;8(13):7240\u20137.","journal-title":"Nanoscale"},{"issue":"3","key":"1066_CR15","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.taap.2006.10.004","volume":"217","author":"W Lin","year":"2006","unstructured":"Lin W, et al. In vitro toxicity of silica nanoparticles in human lung cancer cells. Toxicol Appl Pharmcol. 2006;217(3):252\u20139.","journal-title":"Toxicol Appl Pharmcol"},{"issue":"1","key":"1066_CR16","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/S0939-6411(00)00076-X","volume":"50","author":"C Leuner","year":"2000","unstructured":"Leuner C, Dressman J. Improving drug solubility for oral delivery using solid dispersions. Eur J Pharm Biopharm. 2000;50(1):47\u201360.","journal-title":"Eur J Pharm Biopharm"},{"issue":"2","key":"1066_CR17","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1039\/C2BM00085G","volume":"1","author":"M Colilla","year":"2013","unstructured":"Colilla M, Gonz\u00e1lez B, Vallet-Reg\u00ed M. Mesoporous silica nanoparticles for the design of smart delivery nanodevices. Biomaterials Sci. 2013;1(2):114\u201334.","journal-title":"Biomaterials Sci"},{"issue":"10","key":"1066_CR18","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1021\/ar2000259","volume":"44","author":"JE Lee","year":"2011","unstructured":"Lee JE, et al. Multifunctional mesoporous silica nanocomposite nanoparticles for theranostic applications. Acc Chem Res. 2011;44(10):893\u2013902.","journal-title":"Acc Chem Res"},{"key":"1066_CR19","doi-asserted-by":"publisher","first-page":"4015","DOI":"10.2147\/IJN.S52605","volume":"8","author":"Y Wang","year":"2013","unstructured":"Wang Y, et al. Ordered nanoporous silica as carriers for improved delivery of water insoluble drugs: a comparative study between three dimensional and two dimensional macroporous silica. Int J Nanomed. 2013;8:4015.","journal-title":"Int J Nanomed"},{"issue":"8","key":"1066_CR20","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1002\/adfm.200601191","volume":"17","author":"II Slowing","year":"2007","unstructured":"Slowing II, et al. Mesoporous silica nanoparticles for drug delivery and biosensing applications. Adv Funct Mater. 2007;17(8):1225\u201336.","journal-title":"Adv Funct Mater"},{"issue":"20","key":"1066_CR21","doi-asserted-by":"publisher","first-page":"7175","DOI":"10.1039\/c1jm10803d","volume":"21","author":"J Liu","year":"2011","unstructured":"Liu J, Li C, Li F. Fluorescence turn-on chemodosimeter-functionalized mesoporous silica nanoparticles and their application in cell imaging. J Mater Chem. 2011;21(20):7175\u201381.","journal-title":"J Mater Chem"},{"issue":"1","key":"1066_CR22","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1039\/C2BM00071G","volume":"1","author":"AJ Salinas","year":"2013","unstructured":"Salinas AJ, Esbrit P, Vallet-Reg\u00ed M. A tissue engineering approach based on the use of bioceramics for bone repair. Biomaterials Sci. 2013;1(1):40\u201351.","journal-title":"Biomaterials Sci"},{"issue":"9","key":"1066_CR23","doi-asserted-by":"publisher","first-page":"3847","DOI":"10.1039\/c3cs35359a","volume":"42","author":"N Ehlert","year":"2013","unstructured":"Ehlert N, et al. Mesoporous silica films as a novel biomaterial: applications in the middle ear. Chem Soc Rev. 2013;42(9):3847\u201361.","journal-title":"Chem Soc Rev"},{"issue":"1","key":"1066_CR24","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.ijpharm.2012.09.008","volume":"453","author":"W Xu","year":"2013","unstructured":"Xu W, Riikonen J, Lehto V-P. Mesoporous systems for poorly soluble drugs. Int J Pharm. 2013;453(1):181\u201397.","journal-title":"Int J Pharm"},{"issue":"6","key":"1066_CR25","doi-asserted-by":"publisher","first-page":"819","DOI":"10.3109\/03639045.2013.788013","volume":"40","author":"Y Wang","year":"2014","unstructured":"Wang Y, et al. The investigation of MCM-48-type and MCM-41-type mesoporous silica as oral solid dispersion carriers for water insoluble cilostazol. Drug Dev Ind Pharm. 2014;40(6):819\u201328.","journal-title":"Drug Dev Ind Pharm"},{"issue":"1","key":"1066_CR26","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.ejpb.2010.05.010","volume":"76","author":"Y Zhang","year":"2010","unstructured":"Zhang Y, et al. Inclusion of Telmisartan in mesocellular foam nanoparticles: drug loading and release property. Eur J Pharm Biopharm. 2010;76(1):17\u201323.","journal-title":"Eur J Pharm Biopharm"},{"issue":"1","key":"1066_CR27","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.ijpharm.2011.03.018","volume":"410","author":"S-C Shen","year":"2011","unstructured":"Shen S-C, et al. Physical state and dissolution of ibuprofen formulated by co-spray drying with mesoporous silica: effect of pore and particle size. Int J Pharm. 2011;410(1):188\u201395.","journal-title":"Int J Pharm"},{"issue":"1","key":"1066_CR28","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.ijpharm.2012.10.011","volume":"439","author":"L Jia","year":"2012","unstructured":"Jia L, et al. Successfully tailoring the pore size of mesoporous silica nanoparticles: exploitation of delivery systems for poorly water-soluble drugs. Int J Pharm. 2012;439(1):81\u201391.","journal-title":"Int J Pharm"},{"issue":"1","key":"1066_CR29","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.jcis.2011.07.022","volume":"363","author":"Y Hu","year":"2011","unstructured":"Hu Y, et al. Facile synthesis of 3D cubic mesoporous silica microspheres with a controllable pore size and their application for improved delivery of a water-insoluble drug. J Colloid Interface Sci. 2011;363(1):410\u20137.","journal-title":"J Colloid Interface Sci"},{"key":"1066_CR30","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.msec.2013.08.014","volume":"34","author":"W Zhu","year":"2014","unstructured":"Zhu W, et al. Exploitation of 3D face-centered cubic mesoporous silica as a carrier for a poorly water soluble drug: influence of pore size on release rate. Mater Sci Engineering: C. 2014;34:78\u201385.","journal-title":"Mater Sci Engineering: C"},{"issue":"1","key":"1066_CR31","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.ijpharm.2013.12.017","volume":"461","author":"D Kumar","year":"2014","unstructured":"Kumar D, Chirravuri SS, Shastri NR. Impact of surface area of silica particles on dissolution rate and oral bioavailability of poorly water soluble drugs: a case study with aceclofenac. Int J Pharm. 2014;461(1):459\u201368.","journal-title":"Int J Pharm"},{"issue":"3","key":"1066_CR32","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1007\/s10853-013-7828-1","volume":"49","author":"A Martin","year":"2014","unstructured":"Martin A, et al. Polyethyleneimine-functionalized large pore ordered silica materials for poorly water-soluble drug delivery. J Mater Sci. 2014;49(3):1437\u201347.","journal-title":"J Mater Sci"},{"issue":"3","key":"1066_CR33","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.jconrel.2010.04.029","volume":"145","author":"Y Zhang","year":"2010","unstructured":"Zhang Y, et al. Spherical mesoporous silica nanoparticles for loading and release of the poorly water-soluble drug Telmisartan. J Controlled Release. 2010;145(3):257\u201363.","journal-title":"J Controlled Release"},{"issue":"3","key":"1066_CR34","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.ejps.2013.08.026","volume":"50","author":"RJ Ahern","year":"2013","unstructured":"Ahern RJ, et al. Comparison of fenofibrate\u2013mesoporous silica drug-loading processes for enhanced drug delivery. Eur J Pharm Sci. 2013;50(3):400\u20139.","journal-title":"Eur J Pharm Sci"},{"issue":"8","key":"1066_CR35","doi-asserted-by":"publisher","first-page":"3294","DOI":"10.1002\/jps.22577","volume":"100","author":"T Limnell","year":"2011","unstructured":"Limnell T, et al. Drug delivery formulations of ordered and nonordered mesoporous silica: comparison of three drug loading methods. J Pharm Sci. 2011;100(8):3294\u2013306.","journal-title":"J Pharm Sci"},{"key":"1066_CR36","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.micromeso.2013.02.007","volume":"173","author":"M Khanfar","year":"2013","unstructured":"Khanfar M, Fares MM, Qandil AM. Mesoporous silica based macromolecules for dissolution enhancement of Irbesartan drug using pre-adjusted pH method. Microporous Mesoporous Mater. 2013;173:22\u20138.","journal-title":"Microporous Mesoporous Mater"},{"issue":"3","key":"1066_CR37","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1016\/j.ejpb.2013.08.002","volume":"85","author":"LJ Waters","year":"2013","unstructured":"Waters LJ, et al. Inclusion of Fenofibrate in a series of mesoporous silicas using microwave irradiation. Eur J Pharm Biopharm. 2013;85(3):936\u201341.","journal-title":"Eur J Pharm Biopharm"},{"issue":"40","key":"1066_CR38","doi-asserted-by":"publisher","first-page":"7548","DOI":"10.1002\/anie.200604488","volume":"46","author":"M Vallet-Reg\u00ed","year":"2007","unstructured":"Vallet-Reg\u00ed M, Balas F, Arcos D. Mesoporous materials for drug delivery. Angew Chem Int Ed. 2007;46(40):7548\u201358.","journal-title":"Angew Chem Int Ed"},{"issue":"1","key":"1066_CR39","first-page":"11","volume":"33","author":"DA Labib","year":"2024","unstructured":"Labib DA, et al. Serum soluble Interleukin\u20132 receptor alpha and RANTES chemokine as potential biomarkers for COVID\u201319 infection and severity. Egypt J Med Microbiol. 2024;33(1):11\u20137.","journal-title":"Egypt J Med Microbiol"},{"issue":"8","key":"1066_CR40","doi-asserted-by":"publisher","first-page":"2100035","DOI":"10.1002\/adtp.202100035","volume":"4","author":"IS Pires","year":"2021","unstructured":"Pires IS, Hammond PT, Irvine DJ. Engineering strategies for Immunomodulatory cytokine therapies: challenges and clinical progress. Adv Ther. 2021;4(8):2100035.","journal-title":"Adv Ther"},{"issue":"1","key":"1066_CR41","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1021\/cr00099a003","volume":"90","author":"LL Hench","year":"1990","unstructured":"Hench LL, West JK. The sol-gel process. Chem Rev. 1990;90(1):33\u201372.","journal-title":"Chem Rev"},{"issue":"Suppl","key":"1066_CR42","first-page":"1805","volume":"32","author":"Y Mehmood","year":"2019","unstructured":"Mehmood Y, et al. Facile synthesis of mesoporous silica nanoparticles using modified Solgel method: optimization and in vitro cytotoxicity studies. Pak J Pharm Sci. 2019;32(Suppl):1805\u201312.","journal-title":"Pak J Pharm Sci"},{"issue":"4","key":"1066_CR43","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1208\/s12249-014-0273-x","volume":"16","author":"M Ganesh","year":"2015","unstructured":"Ganesh M, et al. Development of Duloxetine hydrochloride loaded mesoporous silica nanoparticles: characterizations and in vitro evaluation. AAPS PharmSciTech. 2015;16(4):944\u201351.","journal-title":"AAPS PharmSciTech"},{"issue":"2","key":"1066_CR44","doi-asserted-by":"publisher","first-page":"199","DOI":"10.3109\/03639045.2015.1039018","volume":"42","author":"Z Zhao","year":"2016","unstructured":"Zhao Z, et al. Development of novel core-shell dual-mesoporous silica nanoparticles for the production of high bioavailable controlled-release Fenofibrate tablets. Drug Dev Ind Pharm. 2016;42(2):199\u2013208.","journal-title":"Drug Dev Ind Pharm"},{"key":"1066_CR45","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.msec.2014.10.067","volume":"47","author":"L Hu","year":"2015","unstructured":"Hu L, et al. Multilayer encapsulated mesoporous silica nanospheres as an oral sustained drug delivery system for the poorly water-soluble drug felodipine. Mater Sci Engineering: C. 2015;47:313\u201324.","journal-title":"Mater Sci Engineering: C"},{"issue":"20","key":"1066_CR46","doi-asserted-by":"publisher","first-page":"3283","DOI":"10.1002\/adfm.200800521","volume":"18","author":"CH Lee","year":"2008","unstructured":"Lee CH, et al. Synthesis and characterization of positive-charge functionalized mesoporous silica nanoparticles for oral drug delivery of an anti\u2010inflammatory drug. Adv Funct Mater. 2008;18(20):3283\u201392.","journal-title":"Adv Funct Mater"},{"issue":"24","key":"1066_CR47","doi-asserted-by":"publisher","first-page":"7208","DOI":"10.1158\/0008-5472.CAN-16-1681","volume":"76","author":"M Zhang","year":"2016","unstructured":"Zhang M, et al. A hyaluronidase-responsive nanoparticle-based drug delivery system for targeting colon cancer cells. Cancer Res. 2016;76(24):7208\u201318.","journal-title":"Cancer Res"},{"issue":"2","key":"1066_CR48","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1097\/AIA.0b013e318034194e","volume":"45","author":"J-M Zhang","year":"2007","unstructured":"Zhang J-M, An J. Cytokines, inflammation and pain. Int Anesthesiol Clin. 2007;45(2):27.","journal-title":"Int Anesthesiol Clin"},{"key":"1066_CR49","doi-asserted-by":"crossref","unstructured":"Mehmood Y et al. Efficacy and safety of a new Mometasone furoate nasal spray formulation in patients with acute rhinosinusitis: a randomized clinical trial. Italian J Med, 2022. 16(1).","DOI":"10.4081\/itjm.2022.1533"},{"issue":"18","key":"1066_CR50","doi-asserted-by":"publisher","first-page":"4367","DOI":"10.3390\/ijms20184367","volume":"20","author":"KR Patil","year":"2019","unstructured":"Patil KR, et al. Animal models of inflammation for screening of anti-inflammatory drugs: implications for the discovery and development of phytopharmaceuticals. Int J Mol Sci. 2019;20(18):4367.","journal-title":"Int J Mol Sci"},{"issue":"1\u20132","key":"1066_CR51","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/S0022-1759(00)00230-1","volume":"243","author":"P Pala","year":"2000","unstructured":"Pala P, Hussell T, Openshaw PJ. Flow cytometric measurement of intracellular cytokines. J Immunol Methods. 2000;243(1\u20132):107\u201324.","journal-title":"J Immunol Methods"},{"issue":"9\u201310","key":"1066_CR52","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1365\/s10337-009-0982-6","volume":"69","author":"KR Patil","year":"2009","unstructured":"Patil KR, et al. Stability-indicating LC method for analysis of lornoxicam in the dosage form. Chromatographia. 2009;69(9\u201310):1001\u20135.","journal-title":"Chromatographia"},{"issue":"97","key":"1066_CR53","doi-asserted-by":"publisher","first-page":"94896","DOI":"10.1039\/C6RA11799F","volume":"6","author":"F Usman","year":"2016","unstructured":"Usman F, et al. Hydrophilic nanoparticles packed in oral tablets can improve the plasma profile of short half-life hydrophobic drugs. RSC Adv. 2016;6(97):94896\u2013904.","journal-title":"RSC Adv"},{"issue":"27","key":"1066_CR54","doi-asserted-by":"publisher","first-page":"13158","DOI":"10.1021\/jp201017e","volume":"115","author":"Y-D Chiang","year":"2011","unstructured":"Chiang Y-D, et al. Controlling particle size and structural properties of mesoporous silica nanoparticles using the Taguchi method. J Phys Chem C. 2011;115(27):13158\u201365.","journal-title":"J Phys Chem C"},{"key":"1066_CR55","doi-asserted-by":"crossref","unstructured":"Morsi RE, Mohamed RS. Nanostructured mesoporous silica: influence of the Preparation conditions on the physical-surface properties for efficient organic dye uptake. Volume 5. Royal Society open science; 2018. p. 172021. 3.","DOI":"10.1098\/rsos.172021"},{"issue":"2","key":"1066_CR56","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1093\/toxsci\/kfj099","volume":"90","author":"KW Powers","year":"2006","unstructured":"Powers KW, et al. Research strategies for safety evaluation of nanomaterials. Part VI. Characterization of nanoscale particles for toxicological evaluation. Toxicol Sci. 2006;90(2):296\u2013303.","journal-title":"Toxicol Sci"},{"key":"1066_CR57","doi-asserted-by":"publisher","first-page":"67","DOI":"10.2147\/NSA.S91785","volume":"8","author":"MJ Masarudin","year":"2015","unstructured":"Masarudin MJ, et al. Factors determining the stability, size distribution, and cellular accumulation of small, monodisperse Chitosan nanoparticles as candidate vectors for anticancer drug delivery: application to the passive encapsulation of [14\u00a0C]-doxorubicin. Nanatechnol Sci Appl. 2015;8:67.","journal-title":"Nanatechnol Sci Appl"},{"issue":"2","key":"1066_CR58","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s10544-007-9139-2","volume":"10","author":"Y Zhang","year":"2008","unstructured":"Zhang Y, et al. Zeta potential: a surface electrical characteristic to probe the interaction of nanoparticles with normal and cancer human breast epithelial cells. Biomed Microdevices. 2008;10(2):321\u20138.","journal-title":"Biomed Microdevices"},{"key":"1066_CR59","doi-asserted-by":"publisher","first-page":"5577","DOI":"10.2147\/IJN.S36111","volume":"7","author":"E Fr\u00f6hlich","year":"2012","unstructured":"Fr\u00f6hlich E. The role of surface charge in cellular uptake and cytotoxicity of medical nanoparticles. Int J Nanomed. 2012;7:5577.","journal-title":"Int J Nanomed"},{"issue":"5","key":"1066_CR60","doi-asserted-by":"publisher","first-page":"054107","DOI":"10.1063\/1.4962992","volume":"10","author":"KN Clayton","year":"2016","unstructured":"Clayton KN, et al. Physical characterization of nanoparticle size and surface modification using particle scattering diffusometry. Biomicrofluidics. 2016;10(5):054107.","journal-title":"Biomicrofluidics"},{"issue":"3","key":"1066_CR61","doi-asserted-by":"publisher","first-page":"118","DOI":"10.3390\/pharmaceutics10030118","volume":"10","author":"R Narayan","year":"2018","unstructured":"Narayan R, et al. Mesoporous silica nanoparticles: A comprehensive review on synthesis and recent advances. Pharmaceutics. 2018;10(3):118.","journal-title":"Pharmaceutics"},{"key":"1066_CR62","doi-asserted-by":"crossref","unstructured":"Sing K. Reporting physisorption data for gas\/solid systems with special reference to the determination of surface area and porosity (Provisional). Pure and applied chemistry, 1982. 54(11): pp. 2201\u201318.","DOI":"10.1351\/pac198254112201"},{"key":"1066_CR63","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.micromeso.2012.02.037","volume":"158","author":"F Sevimli","year":"2012","unstructured":"Sevimli F, Y\u0131lmaz A. Surface functionalization of SBA-15 particles for amoxicillin delivery. Microporous Mesoporous Mater. 2012;158:281\u201391.","journal-title":"Microporous Mesoporous Mater"},{"issue":"10","key":"1066_CR64","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.1039\/C4TB02073A","volume":"3","author":"F Liu","year":"2015","unstructured":"Liu F, et al. Outside-in Stepwise functionalization of mesoporous silica nanocarriers for matrix type sustained release of fluoroquinolone drugs. J Mater Chem B. 2015;3(10):2206\u201314.","journal-title":"J Mater Chem B"},{"key":"1066_CR65","first-page":"287","volume":"10","author":"A Beganskien\u0117","year":"2004","unstructured":"Beganskien\u0117 A, et al. FTIR, TEM and NMR investigations of St\u00f6ber silica nanoparticles. Mater Sci (Med\u017eiagotyra). 2004;10:287\u201390.","journal-title":"Mater Sci (Med\u017eiagotyra)"},{"issue":"2","key":"1066_CR66","first-page":"277","volume":"8","author":"ST Naik","year":"2016","unstructured":"Naik ST, Venkateswarlu K, Chandrasekhar K. Formulation and in-vitro evaluation of Pregabalin mini tablets for sustained release. Pharm Lett. 2016;8(2):277\u201383.","journal-title":"Pharm Lett"},{"issue":"2\u20133","key":"1066_CR67","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.jconrel.2005.08.017","volume":"108","author":"J Salonen","year":"2005","unstructured":"Salonen J, et al. Mesoporous silicon microparticles for oral drug delivery: loading and release of five model drugs. J Controlled Release. 2005;108(2\u20133):362\u201374.","journal-title":"J Controlled Release"},{"issue":"1","key":"1066_CR68","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.ijpharm.2006.09.019","volume":"331","author":"T Heikkil\u00e4","year":"2007","unstructured":"Heikkil\u00e4 T, et al. Mesoporous silica material TUD-1 as a drug delivery system. Int J Pharm. 2007;331(1):133\u20138.","journal-title":"Int J Pharm"},{"issue":"2","key":"1066_CR69","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1517\/17425247.2015.1111335","volume":"13","author":"A Maleki","year":"2016","unstructured":"Maleki A, Hamidi M. Dissolution enhancement of a model poorly water-soluble drug, atorvastatin, with ordered mesoporous silica: comparison of MSF with SBA-15 as drug carriers. Expert Opin Drug Deliv. 2016;13(2):171\u201381.","journal-title":"Expert Opin Drug Deliv"},{"issue":"7","key":"1066_CR70","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1080\/14656566.2018.1459567","volume":"19","author":"TJ Cory","year":"2018","unstructured":"Cory TJ, et al. Sofosbuvir\u2009+\u2009velpatasvir\u2009+\u2009voxilaprevir for the treatment of hepatitis C infection. Expert Opin Pharmacother. 2018;19(7):749\u201357.","journal-title":"Expert Opin Pharmacother"},{"issue":"4","key":"1066_CR71","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1208\/s12248-009-9144-x","volume":"11","author":"A Dahan","year":"2009","unstructured":"Dahan A, Miller JM, Amidon GL. Prediction of solubility and permeability class membership: provisional BCS classification of the world\u2019s top oral drugs. AAPS J. 2009;11(4):740\u20136.","journal-title":"AAPS J"},{"issue":"24","key":"1066_CR72","doi-asserted-by":"publisher","first-page":"13292","DOI":"10.1039\/C7RA13719B","volume":"8","author":"MM El-Wekil","year":"2018","unstructured":"El-Wekil MM, et al. Enhanced dispersive solid phase extraction assisted by cloud point strategy prior to fluorometric determination of anti-hepatitis C drug velpatasvir in pharmaceutical tablets and body fluids. RSC Adv. 2018;8(24):13292\u2013300.","journal-title":"RSC Adv"},{"issue":"4","key":"1066_CR73","first-page":"1835","volume":"32","author":"Y Mehmood","year":"2019","unstructured":"Mehmood Y, et al. Development and validation of a stability-Indicating RP-HPLC method for simultaneous Estimation of Sofosbuvir and velpatasvir in fixed dose combination tablets and plasma. Pak J Pharm Sci. 2019;32(4):1835\u201342.","journal-title":"Pak J Pharm Sci"},{"issue":"5","key":"1066_CR74","doi-asserted-by":"publisher","first-page":"e02084","DOI":"10.1128\/AAC.02084-16","volume":"61","author":"E Mogalian","year":"2017","unstructured":"Mogalian E, et al. Preclinical pharmacokinetics and First-in-Human pharmacokinetics, Safety, and tolerability of Velpatasvir, a pangenotypic hepatitis C virus NS5A Inhibitor, in healthy subjects. Antimicrob Agents Chemother. 2017;61(5):e02084\u201316.","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"1066_CR75","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.ejpb.2003.12.007","volume":"57","author":"C Charnay","year":"2004","unstructured":"Charnay C, et al. Inclusion of ibuprofen in mesoporous templated silica: drug loading and release property. Eur J Pharm Biopharm. 2004;57(3):533\u201340.","journal-title":"Eur J Pharm Biopharm"},{"issue":"3","key":"1066_CR76","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1021\/mp200287c","volume":"9","author":"Y Zhang","year":"2012","unstructured":"Zhang Y, et al. Mesoporous silica nanoparticles for increasing the oral bioavailability and permeation of poorly water soluble drugs. Mol Pharm. 2012;9(3):505\u201313.","journal-title":"Mol Pharm"},{"key":"1066_CR77","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.ijbiomac.2017.12.026","volume":"110","author":"M Dhanka","year":"2018","unstructured":"Dhanka M, Shetty C, Srivastava R. Methotrexate loaded Gellan gum microparticles for drug delivery. Int J Biol Macromol. 2018;110:346\u201356.","journal-title":"Int J Biol Macromol"},{"issue":"11","key":"1066_CR78","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.1021\/tx300166u","volume":"25","author":"T Asefa","year":"2012","unstructured":"Asefa T, Tao Z. Biocompatibility of mesoporous silica nanoparticles. Chem Res Toxicol. 2012;25(11):2265\u201384.","journal-title":"Chem Res Toxicol"},{"issue":"1","key":"1066_CR79","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.ijpharm.2014.10.010","volume":"478","author":"IU Khan","year":"2015","unstructured":"Khan IU, et al. Microfluidic conceived pH sensitive core\u2013shell particles for dual drug delivery. Int J Pharm. 2015;478(1):78\u201387.","journal-title":"Int J Pharm"},{"issue":"7","key":"1066_CR80","doi-asserted-by":"publisher","first-page":"5390","DOI":"10.1021\/nn200365a","volume":"5","author":"X Huang","year":"2011","unstructured":"Huang X, et al. The shape effect of mesoporous silica nanoparticles on Biodistribution, Clearance, and biocompatibility in vivo. ACS Nano. 2011;5(7):5390\u20139.","journal-title":"ACS Nano"},{"issue":"3","key":"1066_CR81","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1039\/C7TB02292A","volume":"6","author":"TS Anirudhan","year":"2018","unstructured":"Anirudhan TS, Nair AS. Temperature and ultrasound sensitive gatekeepers for the controlled release of chemotherapeutic drugs from mesoporous silica nanoparticles. J Mater Chem B. 2018;6(3):428\u201339.","journal-title":"J Mater Chem B"},{"issue":"6","key":"1066_CR82","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/j.addr.2012.10.007","volume":"65","author":"Y Yun","year":"2013","unstructured":"Yun Y, Cho YW, Park K. Nanoparticles for oral delivery: targeted nanoparticles with peptidic ligands for oral protein delivery. Adv Drug Deliv Rev. 2013;65(6):822\u201332.","journal-title":"Adv Drug Deliv Rev"},{"key":"1066_CR83","doi-asserted-by":"crossref","unstructured":"Javed I et al. Accelerated stability studies of flurbiprofen film coated tablets of five different National brands in Pakistan. J Drug Delivery Ther, 2013. 3(2).","DOI":"10.22270\/jddt.v3i2.402"}],"container-title":["BMC Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12896-025-01066-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12896-025-01066-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12896-025-01066-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T08:02:29Z","timestamp":1788422549000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12896-025-01066-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,13]]},"references-count":83,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1066"],"URL":"https:\/\/doi.org\/10.1186\/s12896-025-01066-1","relation":{},"ISSN":["1472-6750"],"issn-type":[{"value":"1472-6750","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,13]]},"assertion":[{"value":"11 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"126"}}